Updated November 24 at 10:54pm
49 results total, viewing 1 - 10
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Nabsys Inc., a life sciences company that was trying to bring its genome-mapping products to market, closed recently, throwing approximately 40 people out of work. more
Diane Hoffman-Kim is associate professor of medical science and engineering in the Department of Molecular Pharmacology, Physiology, and Biotechnology, and the Center for Biomedical Engineering at Brown University. She was lead author on a recent study showing how miniature brains can be developed in the laboratory for research purposes at surprisingly low cost. more
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
(Updated, 9:20 p.m.) IlluminOss Medical has appointed Manny Avila as its new president and CEO. The developer of a minimally invasive system to repair bone fractures has been looking for a chief executive since former president and CEO Dirk Kuyper left in September 2014. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
EpiVax and French pharmaceutical company Ipsen recently announced a collaborative project to combat neurotoxins with novel biologic therapeutics. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
1 | 2 | 3 | 4 | 5 Next »